CRSP - Latest News
CRISPR Therapeutics AG (CRSP), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $4.83B. Beta to the broader market is 1.76.
The article list below shows the most recent CRSP headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent CRSP Headlines
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know
zacks.com - Oct 12, 2026
CRISPR Therapeutics AG (CRSP) closed at $51. 55 in the latest trading session, marking a -3.
Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock
zacks.com - Oct 12, 2026
Zacks. com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit.
Citi Sees 60% Upside in CRISPR Therapeutics. Here's What Has to Go Right.
fool.com - Oct 9, 2026
Substantial revenue from its flagship drug Casgevy should be right around the corner. Investors can expect a pivotal update on CTX310 before the end
CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2026
globenewswire.com - Oct 8, 2026
ZUG, Switzerland and BOSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that clinical data from the Phase 1
CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You Trade
zacks.com - Oct 6, 2026
The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $54, representing a -5. 82% change from its previous close.
How News Affects CRSP Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track CRSP's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked CRSP news questions
- What is the latest CRSP news headline?
- The most recent CRSP headline (Oct 12, 2026) is "CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the CRSP news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What CRSP news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual CRSP options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.